Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.93
(-0.15%)
CNY 47.93
(-0.15%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.13 Billion CNY | -2.33% |
| 2022 | 1.16 Billion CNY | 63.8% |
| 2021 | 709.13 Million CNY | 48.74% |
| 2020 | 476.76 Million CNY | 51.59% |
| 2019 | 314.5 Million CNY | 78.02% |
| 2018 | 176.67 Million CNY | 26.09% |
| 2017 | 140.11 Million CNY | -7.77% |
| 2016 | 151.91 Million CNY | 29.19% |
| 2015 | 117.59 Million CNY | 113.49% |
| 2014 | 55.08 Million CNY | 29.55% |
| 2013 | 42.51 Million CNY | 29.94% |
| 2012 | 32.72 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.31 Billion CNY | 10.14% |
| 2024 Q1 | 1.16 Billion CNY | 2.28% |
| 2024 Q2 | 1.19 Billion CNY | 2.92% |
| 2023 Q3 | 1.19 Billion CNY | 1.91% |
| 2023 FY | 1.13 Billion CNY | -2.33% |
| 2023 Q2 | 1.17 Billion CNY | -0.31% |
| 2023 Q1 | 1.17 Billion CNY | 1.49% |
| 2023 Q4 | 1.13 Billion CNY | -5.26% |
| 2022 Q3 | 1.07 Billion CNY | 12.49% |
| 2022 Q2 | 957.88 Million CNY | 18.12% |
| 2022 Q1 | 810.9 Million CNY | 14.35% |
| 2022 FY | 1.16 Billion CNY | 63.8% |
| 2022 Q4 | 1.16 Billion CNY | 7.8% |
| 2021 Q1 | 501.96 Million CNY | 5.28% |
| 2021 Q3 | 663.96 Million CNY | 12.55% |
| 2021 Q4 | 709.13 Million CNY | 6.8% |
| 2021 FY | 709.13 Million CNY | 48.74% |
| 2021 Q2 | 589.95 Million CNY | 17.53% |
| 2020 Q2 | 402 Million CNY | 16.21% |
| 2020 FY | 476.76 Million CNY | 51.59% |
| 2020 Q3 | 414.25 Million CNY | 3.05% |
| 2020 Q1 | 345.94 Million CNY | 10.0% |
| 2020 Q4 | 476.76 Million CNY | 15.09% |
| 2019 FY | 314.5 Million CNY | 78.02% |
| 2019 Q1 | 205.37 Million CNY | 16.25% |
| 2019 Q2 | 242.63 Million CNY | 18.14% |
| 2019 Q3 | 266.28 Million CNY | 9.75% |
| 2019 Q4 | 314.5 Million CNY | 18.11% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 176.67 Million CNY | 26.09% |
| 2018 Q4 | 176.67 Million CNY | 0.0% |
| 2017 Q1 | 174.99 Million CNY | -2.07% |
| 2017 Q2 | 174.99 Million CNY | 0.0% |
| 2017 FY | 140.11 Million CNY | -7.77% |
| 2016 Q2 | 167.8 Million CNY | 0.0% |
| 2016 Q4 | 178.7 Million CNY | 0.0% |
| 2016 Q3 | 178.7 Million CNY | 6.49% |
| 2016 Q1 | 167.8 Million CNY | 42.7% |
| 2016 FY | 151.91 Million CNY | 29.19% |
| 2015 Q2 | 74.32 Million CNY | 0.0% |
| 2015 Q3 | 117.59 Million CNY | 58.22% |
| 2015 Q4 | 117.59 Million CNY | 0.0% |
| 2015 Q1 | 74.32 Million CNY | 34.93% |
| 2015 FY | 117.59 Million CNY | 113.49% |
| 2014 FY | 55.08 Million CNY | 29.55% |
| 2014 Q3 | 55.08 Million CNY | 28.63% |
| 2014 Q1 | 42.82 Million CNY | 0.72% |
| 2014 Q2 | 42.82 Million CNY | 0.0% |
| 2014 Q4 | 55.08 Million CNY | 0.0% |
| 2013 FY | 42.51 Million CNY | 29.94% |
| 2013 Q2 | 33.67 Million CNY | 0.0% |
| 2013 Q1 | 33.67 Million CNY | 2.91% |
| 2013 Q4 | 42.51 Million CNY | 0.0% |
| 2013 Q3 | 42.51 Million CNY | 26.26% |
| 2012 FY | 32.72 Million CNY | 0.0% |
| 2012 Q4 | 32.72 Million CNY | 0.0% |
| 2012 Q3 | 32.72 Million CNY | 0.0% |